Analysis of the Beltran 2016 cohort [11] demonstrated significantly higher OPRK1 mRNA in NEPC compared with CRPC-adenocarcinoma (CRPC-AD) (Fig. 1E, F). The gene discussed is OPRK1; the disease is adenocarcinoma.